skip to main content

Atrial fibrillation anticoagulation — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModerateCardiovascular TherapeuticsAtrial fibrillation anticoagulationGPhC CRA

A 76-year-old woman with non-valvular atrial fibrillation asks about stroke prevention. She has hypertension and no history of major bleeding. Her eGFR is 74 mL/min/1.73 m2 and she is not taking interacting medicines. What is the most appropriate action?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: B — Recommend oral anticoagulation and refer for initiation

Age, sex and hypertension give this patient a raised CHA2DS2-VASc score, so oral anticoagulation should be considered for stroke prevention. Antiplatelets are not an adequate substitute for anticoagulation in atrial fibrillation. A newly qualifying pharmacist should identify the need and refer for appropriate prescribing and counselling.

Reference: https://www.pharmacyregulation.org/registration-assessment#stage-8-order-76